Search

everythinglearnresearchcommunity

for

Search:↓

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Oral retinoids are effective for treating severe skin disorders but have reversible side effects and risks for pregnant women.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Using β-cyclodextrin derivatives improves the solubility and bioavailability of steroidal drugs.

Transethosomal gels improve naftifine skin delivery better than Exoderil cream.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

Fesoterodine is effective and safe for elderly patients with overactive bladder.

Spironolactone helps prevent swelling caused by minoxidil in women with hair loss.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Reducing 3α,5α-THP in the hippocampus increases seizures in female rats.

Taking 5 mg/day finasteride can cause side effects in women with hair loss, but these are usually mild and fade over time, making the treatment beneficial in the long run.

Etretinate was effective for certain skin conditions, but caused side effects like chapped lips, dry mucous membranes, and hair loss.

Using both topical and oral minoxidil does not reduce hair shedding.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

Birth control pills help treat acne, especially when caused by excess male hormones, and are safe to use with antibiotics.

Safe treatments like minoxidil and spironolactone can help manage hair loss in breast cancer patients without increasing cancer risk.

Neurosteroids help regulate oxytocin levels, especially during stress and pregnancy, to protect against premature labor.

High doses of nandrolone decanoate disrupt ovarian hormones and receptors in rats, with recovery only at lower doses and longer recovery times.

Low-dose oral minoxidil may be a promising alternative to topical minoxidil for hair loss.

Topical oligonucleotide therapy targets hair follicles effectively.

Ovarian Hyperthecosis caused hypersexuality in an older woman and was successfully treated with surgery.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

Finasteride delivery through skin improved using invasomes and iontophoresis.